"Isoproterenol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
| Descriptor ID |
D007545
|
| MeSH Number(s) |
D02.033.100.291.439 D02.092.063.291.439 D02.092.311.649
|
| Concept/Terms |
Isoproterenol- Isoproterenol
- Isoprenaline
- Isopropylnorepinephrine
- Isopropylarterenol
- Isopropylnoradrenaline
- 4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol
- Isopropyl Noradrenaline
- Noradrenaline, Isopropyl
|
Below are MeSH descriptors whose meaning is more general than "Isoproterenol".
Below are MeSH descriptors whose meaning is more specific than "Isoproterenol".
This graph shows the total number of publications written about "Isoproterenol" by people in this website by year, and whether "Isoproterenol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 3 | 4 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 3 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isoproterenol" by people in Profiles.
-
Dual ablation of the RyR2-Ser2808 and RyR2-Ser2814?sites increases propensity for pro-arrhythmic spontaneous Ca2+ releases. J Physiol. 2024 10; 602(20):5179-5201.
-
AKAP12 Upregulation Associates With PDE8A to Accelerate Cardiac Dysfunction. Circ Res. 2024 Apr 12; 134(8):1006-1022.
-
Phosphorylation of RyR2 simultaneously expands the dyad and rearranges the tetramers. J Gen Physiol. 2024 04 01; 156(4).
-
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises. Heart Rhythm. 2022 10; 19(10):1673-1681.
-
Response of the periodontal tissues to ?-adrenergic stimulation. Life Sci. 2021 Sep 15; 281:119776.
-
Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure. Int J Mol Sci. 2021 Mar 30; 22(7).
-
A Highly Conductive 3D Cardiac Patch Fabricated Using Cardiac Myocytes Reprogrammed from Human Adipogenic Mesenchymal Stem Cells. Cardiovasc Eng Technol. 2020 04; 11(2):205-218.
-
Skeletal muscle microvasculature response to ?-adrenergic stimuli is diminished with cardiac surgery. Surgery. 2020 02; 167(2):493-498.
-
Phosphorylation of the ryanodine receptor 2 at serine 2030 is required for a complete ?-adrenergic response. J Gen Physiol. 2019 02 04; 151(2):131-145.
-
Evolutionary action and structural basis of the allosteric switch controlling ?2AR functional selectivity. Nat Commun. 2017 12 18; 8(1):2169.